CClinicalTrials.gg
CompletedNCT02633891Updated Jun 28, 2024Results posted

Metabolic Syndrome and Fall Risk

An interventional study of Balance exercise and Standard care in Metabolic Syndrome and Autonomic Neuropathy, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-06-28.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Study summary

Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no effective therapies to prevent or reverse the neuropathy seen in the MetS or to reduced the fall risk in this population. This research project will determine if a tailored balance exercise program will have functional benefits and result in a reduced fall risk in the growing population of patients with the MetS and neuropathy.

Read the detailed description

Completed

55 participants with evidence of the MetS and autonomic neuropathy will be assessed for fall risk with the Four Square Step Test (FSST), which is a measure of dynamic standing balance. Additional endpoints include the dynamic gait index. Measures of height, weight, and waist circumference will be taken and an oral glucose tolerance test as well as lipids and blood pressure will also be measured. Autonomic function will be measured using cardiac autonomic testing, quantitative sudomotor axon reflex test and tilt table testing. Participants will be randomized into either a standard care group that will receive fall risk education or a targeted balance exercise intervention group. Both groups will meet once a week. The intervention group will receive a 12 week balance program with personalized incremental increases in the amount and difficulty of each maneuver.

02

Conditions studied

  • Metabolic Syndrome
  • Autonomic Neuropathy

Keywords

  • neuropathies
  • metabolic diseases
  • nervous system diseases
  • peripheral nervous system diseases
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

This study's enrollment of 12 is below the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • MetS at the time of screening based on the International Diabetes Federation definition
  • No risk factors for other causes of neuropathy
  • Autonomic neuropathy as defined by the Toronto Diabetic Neuropathy Expert Group 2010/11 consensus criteria
  • Age 45-75 years inclusive at the time of screening
  • Medically stable at the time of enrollment
  • Able to participate in a standing balance exercise program without constant standby monitoring
  • Women of childbearing potential must be using an acceptable method of contraception for the duration of their participation in the study
  • Willing to accept assignment to either training group
  • Willing and able to participate in the assigned intervention program

Exclusion criteria

Exclusion Criteria:

  • Pregnant women, prisoners, institutionalized subjects and other at risk subjects
  • Etiology of neuropathy other than the MetS
  • History of severe medical conditions likely to shorten lifespan or alter ability to participate in the trial
  • Severe autonomic neuropathy that restricts daily function and the ability to participate in study interventions
  • An inability to understand or cooperate with the procedures of the trial or refusal to sign the informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Balance exercise program

    Participants will attend weekly group training sessions and will keep an exercise log of home activity during a three month exercise program designed to improve balance. Balance exercises will be performed three times per week in a home-based training program.

    Behavioral: Balance exercise

  • Active comparator
    standard care

    Participants will meet in person on a weekly basis for a general education class regarding health and fall prevention but will not participate in an exercise class.

    Behavioral: Standard care

Interventions

  • BehavioralBalance exercise

    tailored balance exercise program

  • BehavioralStandard care

    general health education and fall prevention classes

06

What researchers measure

Primary outcomes

  1. Four Square Step Test (FSST)

    A measure of proactive dynamic standing balance. A participant steps over four canes that are laid on the ground at 90 degree angles to each other. The participants stands in one of the squares formed by the canes and they are instructed to step as quickly as possible into each square in a specified sequence.

    Time frame: 12 weeks

Secondary outcomes

  1. Dynamic Gait Index (DGI)

    An instrumented DGI will be performed on an instrumented gait mat. The DGI is a measure of functional balance during walking and it assesses an individual's ability to modify balance while walking in the presence of external demands (walking while changing speeds, head turns, stepping over and around obstacles, pivoting, and stair climbing). The short form DGI is scored 0-12, with higher number indicating better performance.

    Time frame: 12 weeks

07

Results

Posted Jun 28, 2024

Participant flow

Participant flow — Overall Study
MilestoneBalance Exercise ProgramStandard Care
Started75
Completed54
Not completed21

Outcome measures

PrimaryFour Square Step Test (FSST)

A measure of proactive dynamic standing balance. A participant steps over four canes that are laid on the ground at 90 degree angles to each other. The participants stands in one of the squares formed by the canes and they are instructed to step as quickly as possible into each square in a specified sequence.

Time frame:
12 weeks
Reported as:
Mean · seconds
Four Square Step Test (FSST)
secondsBalance Exercise ProgramStandard Care
Four Square Step Test (FSST)11.04 (9.9 to 12.93)14.29 (9.28 to 25.47)
SecondaryDynamic Gait Index (DGI)

An instrumented DGI will be performed on an instrumented gait mat. The DGI is a measure of functional balance during walking and it assesses an individual's ability to modify balance while walking in the presence of external demands (walking while changing speeds, head turns, stepping over and around obstacles, pivoting, and stair climbing). The short form DGI is scored 0-12, with higher number indicating better performance.

Time frame:
12 weeks
Reported as:
Mean · score on a scale
Dynamic Gait Index (DGI)
score on a scaleBalance Exercise ProgramStandard Care
Dynamic Gait Index (DGI)9.33 (8 to 10)7.5 (3 to 11)

Adverse events

Collected over 3 years. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Balance Exercise Program0/7 (0%)0/7 (0%)—
Standard Care0/5 (0%)0/5 (0%)—

Baseline characteristics

Age, Continuous
Age, Continuous(years)Balance Exercise ProgramStandard CareTotal
Mean66 (53 to 74)66 (59 to 75)66 (53 to 75)
Sex: Female, Male
Sex: Female, Male(Participants)Balance Exercise ProgramStandard CareTotal
Female325
Male437
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Balance Exercise ProgramStandard CareTotal
American Indian or Alaska Native000
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American314
White437
More than one race000
Unknown or Not Reported000
BMI
BMI(kg/m^2)Balance Exercise ProgramStandard CareTotal
Mean35.64 (26.5 to 49.2)38.16 (29.9 to 47.4)36.69 (26.5 to 49.2)
Fasting glucose
Fasting glucose(mg/dL)Balance Exercise ProgramStandard CareTotal
Mean133.86 (97 to 203)108.4 (91 to 130)123.25 (91 to 203)
Four square step test
Four square step test(seconds)Balance Exercise ProgramStandard CareTotal
Mean14.49 (8.62 to 31.56)13.01 (8.15 to 22.6)13.91 (8.15 to 31.56)
Dynamic Gait Index (DGI)
Dynamic Gait Index (DGI)(score on a scale)Balance Exercise ProgramStandard CareTotal
Mean7 (3 to 9)9 (5 to 12)7.73 (3 to 12)
08

Study locations

1 site
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
    Baltimore, Maryland 21201, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 27, 2015
  • Informed consent form · Mar 7, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02633891
Lead sponsor
VA Office of Research and Development
Collaborators
University of Maryland
Responsible party
Sponsor
First posted
Dec 17, 2015
Start date
Jan 2, 2017
Primary completion
Mar 28, 2022
Completion
Mar 28, 2022
Results posted
Jun 28, 2024
Last update
Jun 28, 2024

Study contacts

Lindsay A Zilliox, MD
principal investigator · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion